Answer
Jun 18, 2024 - 10:35 AM
Do you have the same question? Follow this Question
Jun 18, 2024 - 10:35 AM
We’ve provided several answers to questions related to Trelegy Ellipta (Fluticasone Furoate / Umeclidinium / Vilanterol Trifenatate) , see some other helpful Q&A related to this product.
Question: What is Trelegy Ellipta prescribed for?
Answer: Trelegy Ellipta is prescribed for treating chronic obstructive pulmonary disease (COPD) and as a maintenance treatment for asthma in adults. It helps improve breathing and manage symptoms of these conditions.
Question: What precautions should I take when using Trelegy Ellipta?
Answer: Use with caution if you have chronic infections, heart problems, narrow-angle glaucoma, or urinary retention issues. Discuss your medical history with your doctor to ensure safe use of Trelegy Ellipta.
Question: How should I take Trelegy Ellipta?
Answer: Inhale one inhalation of Trelegy Ellipta once daily, and always rinse your mouth with water without swallowing after use. This helps to reduce the risk of developing oropharyngeal candidiasis (thrush) from the ingredient fluticasone.
Question: What is the ATC code for Trelegy Ellipta?
Answer: The ATC code for Trelegy Ellipta is R03AL08. The ATC code is used for the classification of drugs and indicates its therapeutic use.
Question: What is the bioavailability of Trelegy Ellipta?
Answer: The bioavailability of Trelegy Ellipta is 15.2%. Bioavailability indicates the proportion of the drug that enters the circulation when introduced into the body and is available for therapeutic effect.
View all Trelegy Ellipta (Fluticasone Furoate / Umeclidinium / Vilanterol Trifenatate) Questions & Answers